Walleye Trading’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Walleye Trading’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,600	Closed	-$809K	–	5948
2015 Q2	$809K	Buy	19,600 +15,000	+326%	+$538K	0.01%	1282
2015 Q1	$162K	Buy	4,600 +2,400	+109%	+$81.2K	﹤0.01%	2354
2014 Q4	$70K	Buy	2,200 +700	+47%	+$20.2K	﹤0.01%	3036
2014 Q3	$42K	Buy	1,500 +400	+36%	+$12.2K	﹤0.01%	3226
2014 Q2	$33	Sell	1,100 -4,800	-81%	-$132K	﹤0.01%	3055
2014 Q1	$164	Buy	5,900 +5,600	+1,867%	+$147K	﹤0.01%	2059
2013 Q4	$8K	Buy	+300	New	+$9.24K	﹤0.01%	3393

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Walleye Trading's BRLI Position: Q3 2015 in Review

Walleye Trading sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 449 shares — an estimated $19K sold.

Walleye Trading first reported a position in BRLI in Q3 2014 and held it in 3 quarters. The position peaked at $64K in Q4 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Walleye Trading reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Walleye Trading sold 449 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $19K.
Walleye Trading first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2014 and held it in 3 quarters.
Walleye Trading's BIO-REFERENCE LABS INC-NEW- position peaked at $64K in Q4 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Walleye Trading's 13F filing for Q3 2015, filed 16 Nov 2015.